Mammography screening - Neglected aspects of radiation risks;Mammographiescreening - Vernachlässigte aspekte der strahlenrisikobewertung

Gesundheitswesen

Volumn 65, Issue 7, 2003, Pages 443-446

  Kuni, Horst ^a   Schmitz Feuerhake, I ^b   Dieckmann, H ^c  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c Klinik für Radiologische Diagnostik und Nuklearmedizin   (Germany)

Author keywords

Breast cancer screening; Radiation effects of X rays; Radiation risk of mammography; Radiation induced breast cancer; Radiation sensitivity of hereditarily disposed women

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER SCREENING; FEMALE; GENE; GENE MUTATION; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; LOW ENERGY RADIATION; MAMMOGRAPHY; MASS SCREENING; ONCOGENE; RADIATION CARCINOGENESIS; RADIATION HAZARD; RADIOSENSITIVITY; RISK FACTOR; THORAX RADIOGRAPHY; X IRRADIATION;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CLINICAL TRIALS; FEMALE; GENES, BRCA1; GENES, BRCA2; HORMONE REPLACEMENT THERAPY; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MUTATION; NEOPLASMS, RADIATION-INDUCED; RADIATION DOSAGE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 0042656717     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40807     Document Type: Article

References (29)

1. Olsen O, Gøtzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358: 1340-1342
2. Nystrom L, Andersson I, Bjurstam N et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002; 359: 904-905
3. Humphrey LL, Helfand M, Chan BK et al. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137: 347-360
4. Feig SA. Mammographic screening of woman aged 40-49 years. Benefit, risk, and cost considerations. Cancer 1995; 76 (Suppl.): 2097-2106
5. Wun LM, Feuer EJ, Miller AB. Are increases in mammography screening still a valid explanation for trends in breast cancer incidence in the United States? Cancer Causes Control 1995; 6: 135-144
6. Hoffman DA, Lonstein JE, Morin MM et al. Breast cancer in women with scoliosis exposed to multiple diagnostic X rays. J Natl Cancer Inst 1989; 81: 1307-1312
7. Nienhaus A, Hensel N, Roscher G et al. Hormonelle, medizinische und lebensstilbedingte Faktoren und Brustkrebsrisiko. Geburtshilfe und Frauenheilkunde 2002; 62: 242-249
8. International Commission on Radiation Units and Measurements. The quality factor in radiation protection. ICRU Report 40. Bethesda MD: ICRU, 1986
9. R. Health Physics 1995; 69: 954-956
10. Harder D, Regulla D, Schmid E et al. RBW locker ionisierender Strahlungen: Hat ihre LET-Abhängigkeit Bedeutung für den Strahlenschutz? Strahlenschutzpraxis 2001; 7: 23-31
11. Jung H. Abschätzung von Nutzen und Risiko eines Mammographie-screenings unter ausschließlichem Bezug auf das Strahlenrisiko. Radiologe 2001; 41: 385-395
12. Frankenberg D, Kelnhofer K, Bär K et al. Enhanced neoplastic transformation by mammography X rays relative to 200 kVp X rays: indication for a strong dependence on photon energy of the RBE(M) for various end points. Radiat Res 2002; 157: 99-105
13. Greiser E, Günter J, Niemeyer M et al. Weibliche Hormone - Ein Leben lang. Mehr Schaden als Nutzen? In: Wiss. Institut der AOK/Bonn und BIPS/Bremen (Hrsg). Bonn, 2000
14. Committee on the Biological Effects of Ionizing Radiations. Health Effects of Exposure to Low Levels of Ionizing Radiation. Washington D.C.: Nat. Academy Press, 1990
15. Schmitz-Feuerhake I, Kranefeld A, Hormann V. Das Brustkrebsrisiko durch Mammographie. In: Schmitz-Feuerhake I, Lengfelder E (Hrsg). 100 Jahre Röntgen: Medizinische Strahlenbelastung - Bewertung des Risikos. Berlin: Ges. f. Strahlenschutz e.V., 1995; 201-206
16. Strahlenschutzkommission. Mammographie-Screening in Deutschland: Bewertung des Strahlenrisikos. Stellungnahme 2002
17. Dersee T, Dieckmann H, Köhnlein W et al. Brustkrebsfrüherkennung Ja, Reihenuntersuchung mit Mammographie Nein! Berichte des Otto Hug Strahleninstituts 2002; 23: 38
18. Kiechle M, Schmutzler R. Präventive Strategien bei familiärer Brustkrebsprädisposition. Radiologe 2001; 41: 366-370
19. Miller AB, To T, Baines CJ et al. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002; 137 (5 Part 1): 305-312
20. Den Otter W, Merchant TE, Beijering D et al. Exclusion from mammographic screening of women genetically predisposed to breast cancer will probably eliminate mammographically induced breast cancer. Anticancer Res 1993; 13: 1113-1115
21. Den Otter W, Merchant TE, Beijering D et al. Breast cancer induction due to mammographic screening in hereditarily affected women. Anticancer Res 1996; 16: 3173-3176
22. Abbott DW, Freeman ML, Holt JT. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst 1998; 90: 978-985
23. Chakraborty R, Sankaranarayanan K. Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers II. Radiat Res 1995; 143: 293-301
24. Frankenberg D, Frankenberg-Schwager M. Risiken der Mammographie - Physikalische und genetische Aspekte. In: Köhnlein W, Nussbaum RH (Hrsg). Die Wirkung niedriger Strahlendosen. Int. Kongress in Münster 29.-31.3.98. Berlin, Bremen: Ges. f. Strahlenschutz e.V., 2001; 338-344
25. Kuni H. Strahleninduziertes Mammakarzinom: Einfluss von Alter bei Exposition, Latenzzeit, erreichtem Lebensalter und genetischer Prädisposition. In: Köhnlein W, Nussbaum RH (Hrsg). Die Wirkung niedriger Strahlendosen. Int. Kongress in Münster 29.-31.3.98. Berlin, Bremen: Ges. f. Strahlenschutz e.V, 2001; 262-271
26. Frankenberg-Schwager M, Garg I, Frankenberg D et al. Mutagenicity of low-filtered 30kVp X-rays, mammography X-rays and conventional X-rays in cultured mammalian cells. Int J Radiat Biol 2002; 78: 781-789
27. Land CE, Tokunaga M, Tokuoka S et al. Early-onset breast cancer in A-bomb survivors. Lancet 1993; 342: 237
28. Land CE. Studies of cancer and radiation dose among atomic bomb survivors. JAMA 1995; 274: 402-407
29. Fentiman IS. Fixed and modifiable risk factors for breast cancer. Int J Clin Pract 2001; 55: 527-530